JP2017525368A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017525368A5 JP2017525368A5 JP2017509733A JP2017509733A JP2017525368A5 JP 2017525368 A5 JP2017525368 A5 JP 2017525368A5 JP 2017509733 A JP2017509733 A JP 2017509733A JP 2017509733 A JP2017509733 A JP 2017509733A JP 2017525368 A5 JP2017525368 A5 JP 2017525368A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cell
- goi
- binding fragment
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462039416P | 2014-08-19 | 2014-08-19 | |
| US62/039,416 | 2014-08-19 | ||
| PCT/US2015/045793 WO2016028838A1 (en) | 2014-08-19 | 2015-08-19 | Efficient selectivity of recombinant proteins |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020132874A Division JP7260510B2 (ja) | 2014-08-19 | 2020-08-05 | 組み換え型タンパク質の効率的な選択性 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017525368A JP2017525368A (ja) | 2017-09-07 |
| JP2017525368A5 true JP2017525368A5 (enExample) | 2018-09-20 |
| JP7115851B2 JP7115851B2 (ja) | 2022-08-09 |
Family
ID=55347784
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017509733A Active JP7115851B2 (ja) | 2014-08-19 | 2015-08-19 | 組み換え型タンパク質の効率的な選択性 |
| JP2020132874A Active JP7260510B2 (ja) | 2014-08-19 | 2020-08-05 | 組み換え型タンパク質の効率的な選択性 |
| JP2023061971A Active JP7561232B2 (ja) | 2014-08-19 | 2023-04-06 | 組み換え型タンパク質の効率的な選択性 |
| JP2024163845A Pending JP2024166420A (ja) | 2014-08-19 | 2024-09-20 | 組み換え型タンパク質の効率的な選択性 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020132874A Active JP7260510B2 (ja) | 2014-08-19 | 2020-08-05 | 組み換え型タンパク質の効率的な選択性 |
| JP2023061971A Active JP7561232B2 (ja) | 2014-08-19 | 2023-04-06 | 組み換え型タンパク質の効率的な選択性 |
| JP2024163845A Pending JP2024166420A (ja) | 2014-08-19 | 2024-09-20 | 組み換え型タンパク質の効率的な選択性 |
Country Status (27)
| Country | Link |
|---|---|
| US (4) | US9732357B2 (enExample) |
| EP (2) | EP3901274A1 (enExample) |
| JP (4) | JP7115851B2 (enExample) |
| KR (2) | KR102556383B1 (enExample) |
| CN (2) | CN107075549B (enExample) |
| AR (2) | AR102333A1 (enExample) |
| AU (3) | AU2015305565B9 (enExample) |
| CA (1) | CA2957036A1 (enExample) |
| CY (1) | CY1124079T1 (enExample) |
| DK (1) | DK3183359T3 (enExample) |
| EA (1) | EA035340B1 (enExample) |
| ES (1) | ES2849728T3 (enExample) |
| HR (1) | HRP20210301T1 (enExample) |
| HU (1) | HUE054069T2 (enExample) |
| IL (3) | IL287020B (enExample) |
| LT (1) | LT3183359T (enExample) |
| MA (1) | MA40371B1 (enExample) |
| MX (2) | MX384990B (enExample) |
| MY (1) | MY191745A (enExample) |
| PL (1) | PL3183359T3 (enExample) |
| PT (1) | PT3183359T (enExample) |
| RS (1) | RS61371B1 (enExample) |
| SG (2) | SG11201701121UA (enExample) |
| SI (1) | SI3183359T1 (enExample) |
| SM (1) | SMT202100054T1 (enExample) |
| TW (3) | TWI777374B (enExample) |
| WO (1) | WO2016028838A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR102333A1 (es) | 2014-08-19 | 2017-02-22 | Regeneron Pharma | Selectividad eficiente de proteínas recombinadas |
| CN111712566A (zh) | 2018-02-08 | 2020-09-25 | 应用干细胞有限公司 | 用于筛选靶基因变体的方法 |
| EP4049989A4 (en) | 2019-10-23 | 2023-11-29 | Canon Kabushiki Kaisha | Ceramic article production method and ceramic article |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4656134A (en) | 1982-01-11 | 1987-04-07 | Board Of Trustees Of Leland Stanford Jr. University | Gene amplification in eukaryotic cells |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US6077835A (en) | 1994-03-23 | 2000-06-20 | Case Western Reserve University | Delivery of compacted nucleic acid to cells |
| KR970029803A (ko) | 1995-11-03 | 1997-06-26 | 김광호 | 반도체 메모리장치의 프리차지 회로 |
| US5972650A (en) | 1997-06-26 | 1999-10-26 | Brigham And Women's Hospital | Tetracycline repressor regulated mammalian cell transcription and viral replication switch |
| US6281005B1 (en) | 1999-05-14 | 2001-08-28 | Copernicus Therapeutics, Inc. | Automated nucleic acid compaction device |
| EP1242443A4 (en) * | 1999-12-23 | 2005-06-22 | Nuvelo Inc | NEW NUCLEIC ACIDS AND POLYPEPTIDES |
| WO2002057423A2 (en) | 2001-01-16 | 2002-07-25 | Regeneron Pharmaceuticals, Inc. | Isolating cells expressing secreted proteins |
| DK1492874T3 (da) | 2002-03-29 | 2011-03-14 | Xoma Technology Ltd | Multigene vektorplasmider og fremgangsmåder til forøgelse af ekspressionen af rekombinante polypeptider |
| US8673589B2 (en) | 2002-05-29 | 2014-03-18 | Regeneron Pharmaceuticals, Inc. | Inducible eukaryotic expression system |
| US7384744B2 (en) * | 2002-11-29 | 2008-06-10 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products |
| JP2005027599A (ja) * | 2003-07-09 | 2005-02-03 | Nara Institute Of Science & Technology | 植物由来遺伝子を用いた遺伝子導入植物の選抜法 |
| EP1586585A1 (de) * | 2004-04-14 | 2005-10-19 | F. Hoffmann-La Roche Ag | Expressionssystem zur Herstellung von IL-15/Fc-Fusionsproteinen und ihre Verwendung |
| MX2009006093A (es) | 2006-12-07 | 2009-06-17 | Dow Agrosciences Llc | Genes marcadores seleccionables novedosos. |
| WO2008151219A1 (en) | 2007-06-04 | 2008-12-11 | Regeneron Pharmaceuticals, Inc. | Enhanced expression and stability regions |
| KR100927803B1 (ko) * | 2007-11-23 | 2009-11-23 | 한국생명공학연구원 | 식물 형질전환체를 선별하기 위한 마커로서 ｇｐｔ 유전자 |
| KR101603109B1 (ko) * | 2007-12-07 | 2016-03-25 | 지모제넥틱스, 인코포레이티드 | Ｉｌ-31에 특이적인 인간화된 항체 분자 |
| CA2722423A1 (en) * | 2008-04-22 | 2009-10-29 | Rutgers, The State University | Hcv e2 construct compositions and methods |
| EA036569B1 (ru) * | 2008-12-09 | 2020-11-24 | Галозим, Инк. | Способ получения полипептида гиалуронидазы ph20 |
| EP2674495A1 (en) | 2012-06-14 | 2013-12-18 | Sanofi | CHO expression system |
| AR102333A1 (es) * | 2014-08-19 | 2017-02-22 | Regeneron Pharma | Selectividad eficiente de proteínas recombinadas |
-
2015
- 2015-08-14 AR ARP150102631A patent/AR102333A1/es active IP Right Grant
- 2015-08-17 TW TW110101888A patent/TWI777374B/zh active
- 2015-08-17 TW TW111129504A patent/TWI832364B/zh active
- 2015-08-17 TW TW104126657A patent/TWI719945B/zh active
- 2015-08-19 CN CN201580044100.7A patent/CN107075549B/zh active Active
- 2015-08-19 RS RS20210103A patent/RS61371B1/sr unknown
- 2015-08-19 DK DK15833421.9T patent/DK3183359T3/da active
- 2015-08-19 US US14/829,834 patent/US9732357B2/en active Active
- 2015-08-19 EA EA201790241A patent/EA035340B1/ru unknown
- 2015-08-19 SM SM20210054T patent/SMT202100054T1/it unknown
- 2015-08-19 IL IL287020A patent/IL287020B/en unknown
- 2015-08-19 EP EP20211902.0A patent/EP3901274A1/en active Pending
- 2015-08-19 KR KR1020227018877A patent/KR102556383B1/ko active Active
- 2015-08-19 WO PCT/US2015/045793 patent/WO2016028838A1/en not_active Ceased
- 2015-08-19 CN CN202110402963.4A patent/CN113293139B/zh active Active
- 2015-08-19 JP JP2017509733A patent/JP7115851B2/ja active Active
- 2015-08-19 AU AU2015305565A patent/AU2015305565B9/en active Active
- 2015-08-19 MA MA40371A patent/MA40371B1/fr unknown
- 2015-08-19 LT LTEP15833421.9T patent/LT3183359T/lt unknown
- 2015-08-19 SI SI201531487T patent/SI3183359T1/sl unknown
- 2015-08-19 ES ES15833421T patent/ES2849728T3/es active Active
- 2015-08-19 PL PL15833421T patent/PL3183359T3/pl unknown
- 2015-08-19 CA CA2957036A patent/CA2957036A1/en active Pending
- 2015-08-19 KR KR1020177006620A patent/KR102406976B1/ko active Active
- 2015-08-19 SG SG11201701121UA patent/SG11201701121UA/en unknown
- 2015-08-19 HU HUE15833421A patent/HUE054069T2/hu unknown
- 2015-08-19 MX MX2017002203A patent/MX384990B/es unknown
- 2015-08-19 SG SG10201707859RA patent/SG10201707859RA/en unknown
- 2015-08-19 HR HRP20210301TT patent/HRP20210301T1/hr unknown
- 2015-08-19 MY MYPI2017700248A patent/MY191745A/en unknown
- 2015-08-19 PT PT158334219T patent/PT3183359T/pt unknown
- 2015-08-19 EP EP15833421.9A patent/EP3183359B1/en active Active
-
2017
- 2017-02-09 IL IL250531A patent/IL250531B/en unknown
- 2017-02-17 MX MX2021009154A patent/MX2021009154A/es unknown
- 2017-07-31 US US15/664,444 patent/US10457959B2/en active Active
-
2019
- 2019-09-10 US US16/566,253 patent/US11085053B2/en active Active
-
2020
- 2020-07-17 AU AU2020205336A patent/AU2020205336B2/en active Active
- 2020-08-05 JP JP2020132874A patent/JP7260510B2/ja active Active
-
2021
- 2021-02-08 CY CY20211100104T patent/CY1124079T1/el unknown
- 2021-07-02 US US17/366,239 patent/US20210340564A1/en not_active Abandoned
-
2022
- 2022-08-04 IL IL295361A patent/IL295361B2/en unknown
-
2023
- 2023-02-10 AU AU2023200752A patent/AU2023200752B2/en active Active
- 2023-04-06 JP JP2023061971A patent/JP7561232B2/ja active Active
-
2024
- 2024-09-20 JP JP2024163845A patent/JP2024166420A/ja active Pending
- 2024-12-20 AR ARP240103595A patent/AR134798A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111328288B (zh) | 靶向共同抗原的抗原结合蛋白 | |
| CN113784976B (zh) | 用于鉴定抗原特异性t细胞的组合物和方法 | |
| US9127087B2 (en) | High affinity recombinant sea lamprey antibodies selected by a Yeast Surface Display platform | |
| JP2017513479A5 (enExample) | ||
| JP2008520207A (ja) | タンパク質骨格およびその使用 | |
| RU2016136855A (ru) | Биомаркер-направленная многоцелевая иммунотерапия | |
| CN120818057A (zh) | 靶向共同抗原的抗原结合蛋白 | |
| US11390652B2 (en) | Transcriptional regulatory fusion polypeptide | |
| AU2022432849A1 (en) | Analysis, screening, and selection for soluble protein function in secreted protein cell libraries | |
| EP2804875A1 (en) | Tools and methods for expression of membrane proteins | |
| Ludwig et al. | High‐throughput single‐cell sequencing of paired TCRα and TCRβ genes for the direct expression‐cloning and functional analysis of murine T‐cell receptors | |
| JP2005507648A5 (enExample) | ||
| Guo et al. | Balancing the expression and production of a heterodimeric protein: recombinant agkisacutacin as a novel antithrombotic drug candidate | |
| CN119698427A (zh) | 用于预测hla ii类特异性表位和表征cd4+ t细胞的方法和系统 | |
| US20190233843A1 (en) | Transposon system and methods of use | |
| HRP20210301T1 (hr) | Djelotvorna selektivnost rekombinantnih proteina | |
| JP2025519395A (ja) | ウイルスペプチド及びその使用 | |
| JP2009539352A (ja) | パーフォリン−２タンパク質 | |
| CN106397549A (zh) | MERS‑CoV特异性多肽及其应用 | |
| KR102655024B1 (ko) | 표적 특이적인 외래 유전자의 도입 방법 | |
| FI3687287T3 (fi) | Humanisoitua c1q-kompleksia ilmentävät jyrsijät | |
| EP4538285A1 (en) | Pd-1 variant and use thereof | |
| CN103524625B (zh) | 一种新型诱导抗体产生的方法 | |
| CN102329377B (zh) | 狂犬病病毒优势表位肽抗原及其用途 | |
| Basavaraju | Develop and validate novel MHC-II-based T cell detection technologies to interrogate CD4 T cell reactivity and determine key characteristics of neoepitope immunogenicity |